The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125682091 12568209 1 I 20151201 20160707 20160718 20160718 EXP GB-MHRA-EYC 00141824 GB-TEVA-676404ACC TEVA 34.00 YR M Y 80.00000 KG 20160719 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125682091 12568209 1 PS PAROXETINE HYDROCHLORIDE. PAROXETINE HYDROCHLORIDE 1 Oral TAPERED FROM 40MG TO ZERO IN SIX WEEKS U 76618 40 MG ORAL SOLUTION
125682091 12568209 2 C CYCLIZINE HYDROCHLORIDE CYCLIZINE HYDROCHLORIDE 1 0
125682091 12568209 3 C FORTISIP CARBOHYDRATESFATTY ACIDSMINERALSPROTEINVITAMINS 1 0
125682091 12568209 4 C GAVISCON ADVANCE POTASSIUM BICARBONATESODIUM ALGINATE 1 0
125682091 12568209 5 C IBUPROFEN. IBUPROFEN 1 0
125682091 12568209 6 C 5-HYDROXYTRYPTOPHAN OXITRIPTAN 1 0
125682091 12568209 7 C MAGNESIUM MAGNESIUM 1 0
125682091 12568209 8 C OMEGA-3 FISH OIL FISH OILOMEGA-3 FATTY ACIDS 1 0
125682091 12568209 9 C OMEPRAZOLE. OMEPRAZOLE 1 0
125682091 12568209 10 C TEVA UK PROPRANOLOL 2 0
125682091 12568209 11 C VITAMIN B COMPLEX STRONG 2 0
125682091 12568209 12 C VITAMIN C ASCORBIC ACID 1 0
125682091 12568209 13 C VITAMIN D CHOLECALCIFEROL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125682091 12568209 1 Depression
125682091 12568209 2 Nausea

Outcome of event

Event ID CASEID OUTC COD
125682091 12568209 LT
125682091 12568209 HO
125682091 12568209 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125682091 12568209 Agitation
125682091 12568209 Anger
125682091 12568209 Anxiety
125682091 12568209 Back pain
125682091 12568209 Chest pain
125682091 12568209 Chills
125682091 12568209 Condition aggravated
125682091 12568209 Decreased appetite
125682091 12568209 Depression
125682091 12568209 Dizziness
125682091 12568209 Dyschromatopsia
125682091 12568209 Dyskinesia
125682091 12568209 Hyperacusis
125682091 12568209 Hyperhidrosis
125682091 12568209 Hypersensitivity
125682091 12568209 Hypervigilance
125682091 12568209 Hypoaesthesia
125682091 12568209 Insomnia
125682091 12568209 Mood swings
125682091 12568209 Palpitations
125682091 12568209 Peripheral coldness
125682091 12568209 Photophobia
125682091 12568209 Rash
125682091 12568209 Salivary hypersecretion
125682091 12568209 Suicidal ideation
125682091 12568209 Thirst
125682091 12568209 Vertigo
125682091 12568209 Visual impairment
125682091 12568209 Vomiting
125682091 12568209 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125682091 12568209 1 19981201 20151201 0